wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38994327-14777770-21FF-4DFD-BF5C-214D981C46FC
Q38994327-14777770-21FF-4DFD-BF5C-214D981C46FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38994327-14777770-21FF-4DFD-BF5C-214D981C46FC
Targeting MET in Lung Cancer: Will Expectations Finally Be MET?
P2860
Q38994327-14777770-21FF-4DFD-BF5C-214D981C46FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38994327-14777770-21FF-4DFD-BF5C-214D981C46FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed5922a765c51a988e0f27e7df636fd746ffffc6
P2860
A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epi